Nurses’ safety during cancer therapy must be a priority
Intended for healthcare professionals
Opinion Previous     Next

Nurses’ safety during cancer therapy must be a priority

Alison Simons Senior lecturer, pathway award leader, Haematology and cancer, school of health sciences, Birmingham City University
Samantha Toland Senior lecturer, Haematology, school of nursing and midwifery, Birmingham City University

Too many healthcare providers rely on only personal protective equipment for their staff

Nurses administering systemic anticancer therapy (SACT) agents are at risk of consistent exposure to hazardous drugs known to cause health hazards. Long and short-term effects have been noted as including nausea, headaches, dizziness, hair loss and fertility problems (Sessink 2016). They are often putting themselves at risk without adequate protection and awareness, and despite the existence of specific guidance, there are still major inconsistencies in practice that may leave nurses vulnerable to occupational exposure to these hazardous agents.

Cancer Nursing Practice. 18, 1, 14-14. doi: 10.7748/cnp.18.1.14.s14

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more